Labcorp Holdings is trading higher in extended hours following a day of mild pressure during the regular session.
While the company recently announced that its third-quarter financial results are scheduled for release on October 28, 2026, the current move follows positive sentiment regarding the company's NASHnext test, which secured Medicare reimbursement in August and is supported by an IQVIA estimate projecting U.S. peak sales